5AM Ventures, Roche Venture Fund and Sofinnova Partners, three venture capital firms, led a $49m Series A funding round in GlycoEra, a biotechnology company, with participation from LimmaTech Biologics. “We believe GlycoEra’s world-class team has developed a platform that is a step change for the fields of biologics and glycosylation. The platform uniquely enables the translation of glycobiology into meaningful therapeutics via diverse mechanisms and for a wide range of diseases,” Mira Chaurushiya, 5AM Ventures Partner.